Immuron Announces Proposed Public Offering of ADSs

    NEXT STORY
    First Publication from OSE Immunotherapeutics on the Role of SIRPα in the Induction and Maintenance of Immune Tolerance in the American Journal of Transplantation
    PREV STORY
    Cytori Will Become Plus Therapeutics, Inc.
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Amydis Awarded Prion Disease Grant from NIH

    SAN DIEGO, Sept. 26, 2018 (GLOBE NEWSWIRE) -- Amydis, Inc., a privately-held pharmaceutical company ...

    author_avatar
    NASDAQ Market News

    American Gene Technologies Gains Additional Immuno-Oncology Patent

    ROCKVILLE, Md., March 19, 2018 (GLOBE NEWSWIRE) -- American Gene Technologies International Inc. (AGT), ...

    author_avatar
    NASDAQ Market News

    Terveystalo’s network of occupational health services to expand: Terveystalo to acquire Työsyke Oy in Kanta-Häme

    author_avatar
    NASDAQ Market News